New Prognostic Index for Nasopharyngeal Carcinoma
Author Information
Author(s): Toh C-K, Heng D, Ong Y-K, Leong S-S, Wee J, Tan E-H
Primary Institution: National Cancer Centre, Singapore
Hypothesis
Can a new prognostic index score improve the prediction of survival outcomes in patients with disseminated nasopharyngeal carcinoma?
Conclusion
The new prognostic index score effectively stratifies patients into distinct risk groups with significantly different survival outcomes.
Supporting Evidence
- The new prognostic index score stratified patients into three groups with median survivals of 19.6, 14.3, and 7.9 months.
- Significant independent prognostic variables included poor performance status, low hemoglobin levels, and short disease-free interval.
- The maximum score obtainable was 19, with patients categorized into low, intermediate, and high-risk groups.
Takeaway
Doctors created a new scoring system to help predict how long patients with a certain type of cancer might live, and it works well.
Methodology
The study involved univariate and multivariate analyses of clinical features and laboratory parameters in two cohorts of patients.
Potential Biases
Potential bias due to the exclusion of patients not treated with chemotherapy in the analysis.
Limitations
The study may not account for all variables affecting survival, and results are based on specific cohorts treated with chemotherapy.
Participant Demographics
The study included 172 patients with metastatic nasopharyngeal carcinoma, predominantly male, with a median age of 47 years.
Statistical Information
P-Value
0.003
Confidence Interval
95% CI 16.1, 23.1
Statistical Significance
p=0.003
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website